Autoantikörperdiagnostik rheumatologischer systemerkrankungen mit pulmonaler manifestation

Translated title of the contribution: Autoantibody testing in vasculitides and connective tissue diseases with pulmonary manifestations

Julia U. Holle*, E. Csernok, W. L. Gross

*Corresponding author for this work
1 Citation (Scopus)

Abstract

The lung is frequently involved in disorders such as connective tissue diseases and small vessel vasculitides. Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides are often associated with alveolar haemorrhage and pulmonary granulomatous disease, whereas connective tissue disorders present with interstitial lung disease and pulmonary hypertension. Detection of ANCA directed against proteinase 3 or myeloperoxidase is helpful in the diagnosis of ANCA-associated vasculitis, and antinuclear antibodies (ANA) should be determined in cases of suspected connective tissue disease. Autoantibodies determined by ANA differentiation are often very specific for a certain type of connective tissue disease, e.g. antitopoisomerase-1 antibodies for systemic sclerosis. Autoantibody titres may correlate with disease activity or be associated with a special pattern of organ involvement and should be included in the diagnostics of connective tissue diseases and vasculitides.

Translated title of the contributionAutoantibody testing in vasculitides and connective tissue diseases with pulmonary manifestations
Original languageGerman
JournalPneumologe
Volume6
Issue number4
Pages (from-to)213-223
Number of pages11
ISSN1613-5636
DOIs
Publication statusPublished - 2009

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Fingerprint

Dive into the research topics of 'Autoantibody testing in vasculitides and connective tissue diseases with pulmonary manifestations'. Together they form a unique fingerprint.

Cite this